Abstract Meningiomas, the most prevalent brain tumors, constitute nearly 40% of all head tumors, with the majority being benign. Presenting symptoms vary widely, including headaches, vision changes, seizures, and extremity weakness. Given the frequency of meningiomas and their diverse symptoms, access to subspecialty care is crucial for determining treatment necessity. However, existing global healthcare disparities often limit access to the necessary subspecialty care for addressing meningiomas. This literature review investigates the impact of socioeconomic disparities on neuro-oncologic care access, drawing from retrospective cohort studies and multi-cohort analyses. PubMed was utilized to search for articles published between 2000 and 2024, focusing on the relationship between socioeconomic status (SES) and care access, treatment, and outcomes among meningioma patients. Demographic analyses across studies revealed disparities in access to care across age groups, from young adults (20-39 years old) to the elderly (60 years and older). Additionally, disparities were noted among racial and ethnic groups, including African American, Hispanic, and Caucasian populations. Geographic disparities were also evident, with studies spanning regions within the United States and globally, underscoring variations in healthcare access and outcomes. Findings consistently emphasized the disproportionate burden borne by individuals from lower SES backgrounds, characterized by delayed diagnosis, limited treatment options, and poorer survival rates compared to their higher SES counterparts. Structural barriers, such as inadequate health literacy, limited insurance coverage, and geographical constraints, were significant contributors to these disparities, perpetuating health inequities among meningioma patients. Addressing disparities requires comprehensive interventions, including policy reforms to improve insurance coverage, enhance specialist access, and promote culturally sensitive care. Prioritizing initiatives targeting socioeconomic barriers ensures equitable care for all meningioma patients. In conclusion, concerted efforts at all levels are needed to dismantle structural barriers and foster equitable healthcare access and delivery.